Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes

PURPOSE: Immune checkpoint inhibitor (ICI) monotherapy and combination regimens are being actively pursued as strategies to improve durable response rates in cancer patients. However, the biology surrounding combination therapies is not well understood and may increase the likelihood of immune-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggi, J. L., Tan, Y. X., Hartimath, S. V., Jieu, B., Hwang, Y. Y., Jiang, L., Boominathan, R., Cheng, P., Yuen, T. Y., Chin, H. X., Tang, J. R., Larbi, A., Chacko, A. M., Renia, L., Johannes, C., Robins, Edward G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497445/
https://www.ncbi.nlm.nih.gov/pubmed/32705455
http://dx.doi.org/10.1007/s11307-020-01519-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497445/
https://www.ncbi.nlm.nih.gov/pubmed/32705455
http://dx.doi.org/10.1007/s11307-020-01519-3

Ejemplares similares